TipRanks
Avalyn Pharma Inc (AVLN)
NASDAQ:AVLN
US Market

Avalyn Pharma Inc (AVLN) Ratios

7 Followers

Avalyn Pharma Inc Ratios

AVLN's free cash flow for Q2 2026 was $0.00. For the 2026 fiscal year, AVLN's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
Dec 25
Liquidity Ratios
Current Ratio
33.10
Quick Ratio
33.10
Cash Ratio
24.44
Solvency Ratio
-2.05
Operating Cash Flow Ratio
-5.18
Short-Term Operating Cash Flow Coverage
-68.59
Net Current Asset Value
$ 330.67M
Leverage Ratios
Debt-to-Assets Ratio
0.04
Debt-to-Equity Ratio
0.04
Debt-to-Capital Ratio
0.04
Long-Term Debt-to-Capital Ratio
0.04
Financial Leverage Ratio
1.07
Debt Service Coverage Ratio
-48.81
Interest Coverage Ratio
-160.00
Debt to Market Cap
0.01
Interest Debt Per Share
0.39
Net Debt to EBITDA
4.27
Profitability Margins
Gross Profit Margin
0.00%
EBIT Margin
0.00%
EBITDA Margin
0.00%
Operating Profit Margin
0.00%
Pretax Profit Margin
0.00%
Net Profit Margin
0.00%
Continuous Operations Profit Margin
0.00%
Net Income Per EBT
100.00%
EBT Per EBIT
94.27%
Return on Assets (ROA)
-13.12%
Return on Equity (ROE)
-83.23%
Return on Capital Employed (ROCE)
-14.28%
Return on Invested Capital (ROIC)
-14.25%
Return on Tangible Assets
-13.12%
Earnings Yield
-3.99%
Efficiency Ratios
Receivables Turnover
0.00
Payables Turnover
0.04
Inventory Turnover
0.00
Fixed Asset Turnover
0.00
Asset Turnover
0.00
Working Capital Turnover Ratio
0.00
Cash Conversion Cycle
-8.79K
Days of Sales Outstanding
0.00
Days of Inventory Outstanding
0.00
Days of Payables Outstanding
8.79K
Operating Cycle
0.00
Cash Flow Ratios
Operating Cash Flow Per Share
-1.26
Free Cash Flow Per Share
-1.28
CapEx Per Share
0.01
Free Cash Flow to Operating Cash Flow
1.01
Dividend Paid and CapEx Coverage Ratio
-95.34
Capital Expenditure Coverage Ratio
-95.34
Operating Cash Flow Coverage Ratio
-3.27
Operating Cash Flow to Sales Ratio
0.00
Free Cash Flow Yield
-4.05%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-24.43
Price-to-Sales (P/S) Ratio
0.00
Price-to-Book (P/B) Ratio
3.51
Price-to-Free Cash Flow (P/FCF) Ratio
-24.71
Price-to-Operating Cash Flow Ratio
-24.97
Price-to-Earnings Growth (PEG) Ratio
-0.24
Price-to-Fair Value
3.51
Enterprise Value Multiple
-19.87
Enterprise Value
1.15B
EV to EBITDA
-19.87
EV to Sales
0.00
EV to Free Cash Flow
-20.34
EV to Operating Cash Flow
-20.55
Tangible Book Value Per Share
8.99
Shareholders’ Equity Per Share
8.99
Tax and Other Ratios
Effective Tax Rate
0.00
Revenue Per Share
0.00
Net Income Per Share
-1.26
Tax Burden
1.00
Interest Burden
0.96
Research & Development to Revenue
0.00
SG&A to Revenue
0.00
Stock-Based Compensation to Revenue
0.00
Income Quality
1.00
Currency in USD